Medical applications
where every data point can matter
FoRe opens usage perspectives in several medical and scientific environments where timing, sample volume and access to selected biological data can become critical issues.
A platform designed for several sensitive contexts.
In certain medical environments, the time required to access biological information, the amount of blood available or the logistical complexity of analyses can affect care organization, research or monitoring.
Less sample volume,
more information potential.
In pediatrics and neonatology, the available blood volume is a particularly sensitive issue. FoRe is designed to perform selected immunological analyses from a very small blood volume.
Analysis possible from less than 50 µL of blood.
Strong potential for situations where rapid results are critical.
Reducing access times
to selected biological data.
FoRe aims to support faster access to selected biological data close to care environments, while respecting the role of hospital laboratories and medical teams.
A technology designed to operate closer to the point of care.
A usage model compatible with healthcare and laboratory settings.
Monitoring selected biomarkers
with greater proximity.
FoRe opens perspectives for simultaneous quantification of selected biomarkers in research, monitoring or evaluation contexts requiring faster, more accessible and less restrictive tools.
An approach aligned with the growing need for personalized care pathways.
Applications to be further developed and structured through data generation, protocols, and strategic partnerships.
Accelerating access to information
in infectious contexts.
FoRe is designed to support a faster analysis dynamic, with a portable platform that can be adapted to different biomarkers depending on medical, scientific or hospital needs.
An approach designed to reduce delays in accessing critical biological information.
A platform tool
to explore, test and compare.
FoRe is relevant for clinical and preclinical research, especially for assay transfer, monitoring selected biomarkers or working in contexts requiring more compact and faster analysis.
Additional information
for qualified contacts.
Some technical, scientific or strategic documents may be shared in a private framework after contacts have been qualified.
Technical and scientific materials intended for researchers, hospitals, and laboratories seeking to gain a deeper understanding of the technology and its conditions of use.
Presentation materials and strategic information intended for specialized investors evaluating the medtech opportunity.
Would you like to assess FoRe’s potential
in your field?
Preciphos offers qualified discussions with medical, hospital, scientific, institutional or industrial contacts.